Cannabinoid receptor agonists and antagonists stimulate insulin secretion from isolated human islets of Langerhans

Diabetes, Obesity and Metabolism

Volumn 13, Issue 10, 2011, Pages 903-910

  Li, C ^a   Bowe, J E ^a   Huang, G C ^a   Amiel, S A ^a   Jones, P M ^a   Persaud, Shanta J ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

Cannabinoids; Insulin secretion; Islets; cell

Indexed keywords

1 (2,4 DICHLOROPHENYL) 5 (4 IODOPHENYL) 4 METHYL N (1 PIPERIDYL) 1H PYRAZOLE 3 CARBOXAMIDE; 2 ARACHIDONOYLGLYCEROL; 2 METHYL 3 (1 NAPHTHOYL) 1 PROPYLINDOLE; ARACHIDONOYL 2 CHLOROETHYLAMIDE; ARACHIDONYOLCYCLOPROPYLAMIDE; CANNABINOID 1 RECEPTOR; CANNABINOID 2 RECEPTOR; CANNABINOID RECEPTOR AGONIST; CANNABINOID RECEPTOR ANTAGONIST; INSULIN; JTE 907; N (1,3 BENZODIOXOL 5 YLMETHYL) 1,2 DIHYDRO 7 METHOXY 2 OXO 8 (PENTYLOXY) 3 QUINOLINE CARBOXAMIDE; UNCLASSIFIED DRUG;

ARTICLE; DRUG MECHANISM; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INSULIN RELEASE; PANCREAS ISLET; PANCREAS ISLET BETA CELL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; RADIOIMMUNOASSAY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

EID: 80052526229     PISSN: 14628902     EISSN: 14631326     Source Type: Journal    
DOI: 10.1111/j.1463-1326.2011.01422.x     Document Type: Article

References (39)

1. Dewey WL. Cannabinoid pharmacology. Pharmacol Rev 1986; 38: 151-178.
2. Matsuda LA, Lolait SJ, Brownstein MJ, Young AC, Bonner TI. Structure of a cannabinoid receptor and functional expression of the cloned cDNA. Nature 1990; 346: 561-564.
3. Munro S, Thomas KL, Abu-Shaar M. Molecular characterization of a peripheral receptor for cannabinoids. Nature 1993; 365: 61-65.
4. Howlett AC, Barth F, Bonner TI et al. International Union of Pharmacology. XXVII. Classification of cannabinoid receptors. Pharmacol Rev 2002; 54: 161-202.
5. Lopez de Jesus M, Salles J, Meana JJ, Callado LF. Characterization of CB1 cannabinoid receptor immunoreactivity in postmortem human brain homogenates. Neuroscience 2006; 140: 635-643.
6. Walter L, Franklin A, Witting A et al. Nonpsychotropic cannabinoid receptors regulate microglial cell migration. J Neurosci 2003; 23: 1398-1405.
7. Van Sickle MD, Duncan M, Kingsley PJ et al. Identification and functional characterization of brainstem cannabinoid CB2 receptors. Science 2005; 310: 329-332.
8. Goparaju SK, Ueda N, Taniguchi K, Yamamoto S. Enzymes of porcine brain hydrolyzing 2-arachidonoylglycerol, an endogenous ligand of cannabinoid receptors. Biochem Pharmacol 1999; 57: 417-423.
9. Gardner EL, Vorel SR. Cannabinoid transmission and reward-related events. Neurobiol Dis 1998; 5: 502-533.
10. Williams CM, Kirkham TC. Observational analysis of feeding induced by Delta(9)-THC and anandamide. Physiol Behav 2002; 76: 241-250.
11. Kirkham TC, Williams CM, Fezza F, Di Marzo V. Endocannabinoid levels in rat limbic forebrain and hypothalamus in relation to fasting, feeding and satiation: stimulation of eating by 2-arachidonoyl glycerol. Br J Pharmacol 2002; 136: 550-557.
12. Colombo G, Agabio R, Diaz G, Lobina C, Reali R, Gessa GL. Appetite suppression and weight loss after the cannabinoid antagonist SR141716. Life Sci 1998; 63: PL113-PL117.
13. Ravinet Trillou C, Delgorge C, Menet C, Arnone M, Soubrie P. CB1 cannabinoid receptor knockout in mice leads to leanness, resistance to diet-induced obesity and enhanced leptin sensitivity. Int J Obes Relat Metab Disord 2004; 28: 640-648.
14. Cota D, Marsicano G, Tschop M et al. The endogenous cannabinoid system affects energy balance via central orexigenic drive and peripheral lipogenesis. J Clin Invest 2003; 112: 423-431.
15. Esfandyari T, Camilleri M, Busciglio I, Burton D, Baxter K, Zinsmeister AR. Effects of a cannabinoid receptor agonist on colonic motor and sensory functions in humans: a randomized, placebo-controlled study. Am J Physiol 2007; 293: G137-G145.
16. Osei-Hyiaman D, DePetrillo M, Pacher P et al. Endocannabinoid activation at hepatic CB1 receptors stimulates fatty acid synthesis and contributes to diet-induced obesity. J Clin Invest 2005; 115: 1298-1305.
17. Eckardt K, Sell H, Taube A et al. Cannabinoid type 1 receptors in human skeletal muscle cells participate in the negative crosstalk between fat and muscle. Diabetologia 2009; 52: 664-674.
18. Cota D. CB1 receptors: emerging evidence for central and peripheral mechanisms that regulate energy balance, metabolism, and cardiovascular health. Diabetes Metab Res Rev 2007; 23: 507-517.
19. Scheen AJ. Cannabinoid-1 receptor antagonists in type-2 diabetes. Best Pract Res Clin Endocrinol Metab 2007; 21: 535-553.
20. Li C, Jones PM, Persaud SJ. Role of the endocannabinoid system in food intake, energy homeostasis and regulation of the endocrine pancreas. Pharmacol Ther 2011; 129: 307-320.
21. Huang GC, Zhao M, Jones PM et al. The development of new density gradient media for the purification of human islets and islet quality assessments. Transplantation 2004; 77: 143-145.
22. Persaud SJ, Belin VD, Muller D et al. The role of arachidonic acid and its metabolites in insulin secretion from human islets of Langerhans. Diabetes 2007; 56: 197-203.
23. 2+, cyclic AMP, a phorbol ester and noradrenaline. Biochem J 1988; 254: 397-403.
24. Li C, Bowe JE, Jones PM, Persaud SJ. Expression and function of cannabinoid receptors in mouse islets. Islets 2010; 2: 1-10.
25. Li C, Jones PM, Persaud SJ. Cannabinoid receptors are coupled to stimulation of insulin secretion from mouse MIN6 beta-cells. Cell Physiol Biochem 2010; 26: 187-196.
26. de Kloet AD, Woods SC. Minireview: Endocannabinoids and their receptors as targets for obesity therapy. Endocrinology 2009; 150: 2531-2536.
27. 2+ signals and insulin secretion in pancreatic beta-cell. Cell Calcium 2006; 39: 155-162.
28. Bermudez-Silva FJ, Sanchez-Vera I, Suarez J et al. Role of cannabinoid CB2 receptors in glucose homeostasis in rats. Eur J Pharmacol 2007; 565: 207-211.
29. 2+ oscillation in islet beta-cells via CB1 receptors. Regul Pept 2008; 145: 49-53.
30. Starowicz KM, Cristino L, Matias I et al. Endocannabinoid dysregulation in the pancreas and adipose tissue of mice fed with a high-fat diet. Obesity 2008; 16: 553-565.
31. Bermudez-Silva FJ, Suarez J, Baixeras E et al. Presence of functional cannabinoid receptors in human endocrine pancreas. Diabetologia 2008; 51: 476-487.
32. Tharp WG, Lee YH, Maple RL, Pratley RE. The cannabinoid CB1 receptor is expressed in pancreatic delta-cells. Biochem Biophys Res Commun 2008; 372: 595-600.
33. Matias I, Gonthier MP, Orlando P et al. Regulation, function, and dysregulation of endocannabinoids in models of adipose and beta-pancreatic cells and in obesity and hyperglycemia. J Clin Endocrinol Metab 2006; 91: 3171-3180.
34. Vilches-Flores A, Delgado-Buenrostro NL, Navarrete-Vazquez G, Villalobos-Molina R. CB1 cannabinoid receptor expression is regulated by glucose and feeding in rat pancreatic islets. Regul Pept 2010; 163: 81-87.
35. de Petrocellis L, Marini P, Matias I et al. Mechanisms for the coupling of cannabinoid receptors to intracellular calcium mobilization in rat insulinoma β-cells. Exp Cell Res 2007; 313: 2993-3004.
36. Ryberg E, Larsson N, Sjogren S et al. The orphan receptor GPR55 is a novel cannabinoid receptor. Br J Pharmacol 2007; 152: 1092-1101.
37. Lauckner JE, Hille B, Mackie K. The cannabinoid agonist WIN55, 212-2 increases intracellular calcium via CB1 receptor coupling to G(q/11) G proteins. Proc Natl Acad Sci U S A 2005; 102: 19144-19149.
38. Persaud SJ, Jones PM. Sugden D & Howell SL. The role of protein kinase C in cholinergic stimulation of insulin secretion from rat islets of Langerhans. Biochem J 1989; 264: 753-758.
39. Persaud SJ, Jones PM, Howell SL. Stimulation of insulin secretion by cholecystokinin-8S: the role of protein kinase C. Pharmacol Commun 1989; 3: 39-47.